AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03220854 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy
Description: Treatment will be planned to deliver a total of 18 to 60 Gy to the planning target volume (PTV) in 3 to 5 fractions over 1 to 2 weeks.
Study NCT03220854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological: humanized anti-PD-1 monoclonal antibody
Description: Standard of Care - patient will continue to be given the same PD-1 inhibitor they were receiving prior to study registration
Study NCT01555268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT01653496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery
Description: The main 18 elements of ERAS program included are described in detail in the brief summary of the study
Study NCT03836963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive training
Description: Cognitive training consists of a set of computerize games played on an iPad at home. Training will include 4 sessions/week for 8 weeks. Each session will take 30min. Total hours of training is 16 hours.
Study NCT03836963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive training
Description: Cognitive training consists of a set of computerize games played on an iPad at home. Training will include 4 sessions/week for 8 weeks. Each session will take 30min. Total hours of training is 16 hours.
Study NCT03836963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: active control cognitive training
Description: The active control consists of a set of computerized games played on an iPad. Training will include 4 sessions/week for 8 weeks. Each session will take 30min. Total hours of training is 16 hours.
Study NCT03836963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: memory strategy training
Description: the participant's prospective memory strategies will be developed with researchers. Participants will be engage in the strategies daily; this will take only a few minutes a day to accomplish.
Study NCT03836963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: memory strategy training
Description: the participant's prospective memory strategies will be developed with researchers. Participants will be engage in the strategies daily; this will take only a few minutes a day to accomplish.
Study NCT02067910 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abatacept SC
Description: Weekly subcutaneous administration of 125 mg Abatacept
Study NCT02067910 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Abatacept SC
Description: Weekly subcutaneous administration of 125 mg Abatacept
Study NCT03608514 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Experimental
Description: Patients in this arm of the study will receive intravenous infusion (IVi) terlipressin by rate 1-2µg/kg/min.
Study NCT03608514 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Experimental
Description: Patients in this arm of the study will receive intravenous infusion (IVi) terlipressin by rate 1-2µg/kg/min.
Study NCT03375021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CX717 200 mg
Description: CX717 200 mg capsules BID
Study NCT03375021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CX717 800 mg
Description: CX717 4 X 200 mg capsules BID
Study NCT03375021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo 200 mg or 800 mg capsules BID
Study NCT01242956 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: verum group
Description: video-based training after stroke
Study NCT01242956 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: non-video group
Study NCT00857220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: eszopiclone
Description: One 2 mg tablet per day for 12 months
Study NCT00857220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: eszopiclone
Description: one 3mg tablet per day for 12 months
Study NCT01600092 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RotaTeq™ existing formulation
Study NCT05380167 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BRJ Nitrate
Description: Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink with nitrate.
Study NCT05380167 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: BRJ Placebo
Description: Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink without nitrate
Study NCT02982083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Raloxifene hydrochloride
Description: 20 patients consume raloxifene hydrochloride oral tablet daily for one year.
Study NCT02982083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: 20 patients consume placebo oral tablets daily for one year.
Study NCT01410188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPA-6566
Description: OPA-6566, 2 dosing schedules (one drop once per day for 2 weeks and twice per day for 2 weeks)
Study NCT01410188 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, 2 dosing schedules (one drop once per day for 2 weeks and twice per day for 2 weeks)
Study NCT01410188 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost
Description: Latanoprost (one drop once per day for 4 weeks)
Study NCT01900288 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HPN Group Clinic Appointments using Mobile Devices (experimental)
Description: Visual meetings with geographically distant professionals and peers using a mobile device (iPad mini).
Study NCT01900288 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Mobile Device Access (placebo)
Description: Use of iPad mini unrelated to the intervention until last contact with one connection to professionals for comparison.
Study NCT04911972 — intervention group
Intervention type: PROCEDURE
Intervention: Functional muscle transfer
Description: Muscle transfer to restore lower limb function
Study NCT01170078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epoetin Hospira
Description: IV dose 3 times a week.
Study NCT01170078 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epogen
Description: IV dose 3 times a week
Study NCT00875862 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interscalene catheter with Ropivicaine or normal saline
Description: Patients will be randomized to one of two groups: 0.2% Ropiviciane or normal saline in the infusion pump, following a shoulder manipulation for adhesive capsulitis. The patients will be followed by doctors and study staff to assess pain, range-of-motion and quality-of-life.
Study NCT00875862 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Interscalene catheter with Ropivicaine or normal saline
Description: Patients will be randomized to one of two groups: 0.2% Ropiviciane or normal saline in the infusion pump, following a shoulder manipulation for adhesive capsulitis. The patients will be followed by doctors and study staff to assess pain, range-of-motion and quality-of-life.
Study NCT02178267 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (biogai AB, Sweden)
Description: Lactobacillus reuteri (biogai AB, Sweden) was given to probiotic group, same way to all newborn newborn preterm infants, directly oral feeding and without any along with a mixture, admission following the in nicu, as a daily dose 1x108 cfu / day (1x5 drops / day) during hospitalization
Study NCT02678299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PREBEN
Study NCT04684992 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GEBT Telehealth Administration Usability
Description: Establish the usability of a telehealth platform for the administration of GEBT
Study NCT01137019 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biolimus-eluting stent
Description: The biolimus-eluting coronary stent contains a stainless steel platform on which an abluminally coated polylactic acid (PLA) biodegradable polymer is placed that eludes biolimus-A9.
Study NCT01137019 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Everolimus-eluting coronary stent
Description: The everolimus-eluting coronary stent is a cobalt chromium platform stent with a permanent fluorinated copolymer matrix that eludes everolimus
Study NCT03459456 — intervention group
Intervention type: BEHAVIORAL
Intervention: Provocation OC task (Provoc)
Description: used to evoke OC-related distress
Study NCT03459456 — intervention group
Intervention type: BEHAVIORAL
Intervention: Trier Social Stress Test (TSST)
Description: used to evoke anxiety unrelated to OCD (e.g., performance anxiety)
Study NCT03459456 — intervention group
Intervention type: BEHAVIORAL
Intervention: Exposure provocation task
Description: used to elicit overt OCD rituals
Study NCT03436823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nurse semi-structured interview
Description: The first session of rTMS is D1. From the first meeting to D14 semi -structured interviews are set up
Study NCT03436823 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Music & Relaxation with eyes closed
Description: The first session of rTMS is D1. From the first meeting to D14 music \& relaxation with eyes closed sessions are set up
Study NCT01848366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biowave Treatment
Description: Twelve weekly treatments
Study NCT02461888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Chemotherapy
Study NCT02461888 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Chemotherapy
Study NCT02461888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Chemotherapy
Study NCT02461888 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Chemotherapy
Study NCT02461888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Chemotherapy
Study NCT01010152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Codeine Sulfate
Description: 30 mg Tablet
Study NCT01010152 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Codeine Sulfate
Description: 30 mg Tablet
Study NCT06071156 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anakinra
Description: Anakinra, an IL-1 antagonist, is particularly interesting because it limits the self-sustained pathway of recurrent pericarditis and may reduce the recurrences
Study NCT00303888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: Given IV
Study NCT00303888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: idronoxil
Description: Given orally
Study NCT00303888 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: Given orally
Study NCT00712803 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rDEN3-3'D4delta30
Description: Live attenuated 10\^3 dose of rDEN3-3'D4delta30 vaccine.
Study NCT00712803 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rDEN3-3'D4delta30
Description: Live attenuated 10\^5 dose of rDEN3-3'D4delta30 vaccine.
Study NCT00712803 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rDEN3-3'D4delta30
Description: Live attenuated 10\^1 dose of rDEN3-3'D4delta30 vaccine.
Study NCT01676623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard government health services
Description: This intervention will be basic preventive and curative health services provided by the commune health centers. This includes antenatal care, postnatal care and basic nutrition related counseling.
Study NCT01676623 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard government health services
Description: This intervention will be basic preventive and curative health services provided by the commune health centers. This includes antenatal care, postnatal care and basic nutrition related counseling.
Study NCT01676623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alive & Thrive IYCF franchise services
Description: This intervention includes intensive behavioral counseling to improve infant and young child feeding. A package of 15 counseling contacts that are quality assured and branded will be offered to families of infants and young children. Services might also include user fees.
Study NCT01676623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mass media campaign
Description: Alive \& Thrive is implementing a nationwide mass media campaign in 2011, 2012 and 2013, with a focus on improving breastfeeding practices. The mass media intervention includes TV and radio spots as well as an internet site and a telephone hotline.
Study NCT01676623 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mass media campaign
Description: Alive \& Thrive is implementing a nationwide mass media campaign in 2011, 2012 and 2013, with a focus on improving breastfeeding practices. The mass media intervention includes TV and radio spots as well as an internet site and a telephone hotline.
Study NCT03493984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ginger exosomes
Description: Naturally occurring plant exosomes from ginger
Study NCT03493984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aloe exosomes
Description: Naturally occurring plant exosomes from aloe
Study NCT03493984 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Exosome placebo tablet
Study NCT00352521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab
Study NCT00352521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irinotecan
Study NCT00488904 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: supportan
Description: 2 sip feed pr. day
Study NCT00352521 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dynamic contrast-enhanced magnetic resonance imaging
Study NCT06240156 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D arch pad design Insole group
Description: 3D three-dimensional design that is already available on the market (patent number I315187). Its arch support principle is designed using 3DBS (Three-Dimensional Biomechanics System - 3DBS), which can conform to the user's feet.
Study NCT06240156 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: flat Insole group
Description: General Insole without any special features
Study NCT02423538 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302
Description: Oral tablets (1 mg, 5 mg, 10 mg)
Study NCT00488904 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: supportan placebo
Description: 2 sip feed pr. day
Study NCT02483949 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus
Study NCT02423538 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SHR0302 placebo comparator
Description: Oral tablets (1 mg, 5 mg, 10 mg) (matching corresponding study medication)
Study NCT04956588 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: surgical robot
Description: The surgical robot completed the screw placement according to the surgical plan, and the researchers closely monitored the screw placement process.
Study NCT04956588 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: controlled approach
Description: The screw placement was performed using a controlled approach according to the surgical plan.
Study NCT03972956 — intervention group
Intervention type: OTHER
Intervention: No intervention will be given to patients.
Description: Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Study NCT03251950 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: healthy eating and gardening
Description: 15 week healthy eating and gardening intervention for children aged 3-5 years; 15 week online parenting intervention to promote healthy eating; Menu change in early childhood center to promote healthy eating
Study NCT03251950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: healthy eating and gardening
Description: 15 week healthy eating and gardening intervention for children aged 3-5 years; 15 week online parenting intervention to promote healthy eating; Menu change in early childhood center to promote healthy eating
Study NCT03323866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide 0.5 MG/ML
Description: 2 cc nebule of budesonide in 240 cc of saline water (Sinus Rinse) once daily
Study NCT03323866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone nasal spray
Description: Mometasone 50 mcg/spray 2 sprays twice daily
Study NCT03842072 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cervical collar
Description: cervical collars prescribed will be use immediately following anterior cervical discectomy and fusion surgery.
Study NCT03137693 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care Schedule Variation: SABR
Description: SABR will be delivered over 3 days, prior to surgery.
Study NCT03220854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological: humanized anti-PD-L1 monoclonal antibody
Description: Standard of Care - patient will continue to be given the same PD-L1 inhibitor they were receiving prior to study registration
Study NCT00429429 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Description: Drops of peanut protein placed and held under the tongue for a specific time before swallowed.
Study NCT00788541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anecortave Acetate Sterile Suspension, 60 mg/ML
Description: Administered as an injection into an anterior juxtascleral depot
Study NCT00788541 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Anecortave Acetate Vehicle
Description: Administered as an injection into an anterior juxtascleral depot
Study NCT02430259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Weekly INH / RRT given by DOT
Description: weekly oral Rifapentine 15 mg/kg (up to 900mg) plus Isoniazid 15 mg/kg (up to 900mg) for 12 doses
Study NCT06075641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gingival depigmentation
Description: Gingival depigmentation is the most widely used periodontal procedure to remove or reduce the melanotic areas. Various techniques can be employed to effectively carry out the depigmentation procedure, including surgical scraping, scalpel technique, bur abrasion, free gingival graft, gingivectomy, cryosurgery, electrosurgery, chemical therapies, and different types of lasers
Study NCT06075641 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Gingival depigmentation
Description: Gingival depigmentation is the most widely used periodontal procedure to remove or reduce the melanotic areas. Various techniques can be employed to effectively carry out the depigmentation procedure, including surgical scraping, scalpel technique, bur abrasion, free gingival graft, gingivectomy, cryosurgery, electrosurgery, chemical therapies, and different types of lasers
Study NCT01724905 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Modified Stop Light Diet (SLDm)
Description: SLDm includes reduced energy pre-packaged meals (PM) for 6 months, encouraged consumption of low energy shakes and 35 fruits and vegetables (F/V) per week
Study NCT01724905 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Recommended Care Diet
Description: RC diet includes traditional meal plans and 35 fruits and vegetables per week
Study NCT00199524 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Navigator Ureteral Access Sheath
Description: ureteral access sheath
Study NCT00853099 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: adalimumab
Study NCT00853099 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: adalimumab
Study NCT00578630 — intervention group
Intervention type: OTHER
Intervention: buccal swabs and obtaining peripheral blood
Description: will be the collection of normal cells and assessments of toxicity following chemotherapy at routine clinic visits.
Study NCT01362387 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alternative follow-up protocol
Description: Women (n=1000) will be allocated by chance to one of two groups: alternative follow-up using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test, or standard follow-up which consists of an in person visit with an ultrasound or a telephone call and high sensitivity pregnancy test.
Study NCT00437255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clobetasol Propionate, 0.05%
Description: Topical, twice daily for 4 weeks
Study NCT00437255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcipotriene and betamethasone dipropionate ointment
Description: Topical, once daily